{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:57:01Z","timestamp":1760954221279,"version":"3.40.5"},"reference-count":52,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s227166","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T20:41:41Z","timestamp":1593549701000},"page":"6405-6416","source":"Crossref","is-referenced-by-count":12,"title":["<p>Clinical Utility of Selinexor\/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection<\/p>"],"prefix":"10.2147","volume":"Volume 13","author":[{"given":"Panagiotis","family":"Malandrakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6328-9783","authenticated-orcid":true,"given":"Ioannis","family":"Ntanasis-Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gavriatopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-1422","authenticated-orcid":true,"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.25791","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"101929","DOI":"10.1016\/j.ctrv.2019.101929","volume":"82","author":"Ntanasis-Stathopoulos","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14712598.2020.1717464","volume":"20","author":"Ntanasis-Stathopoulos","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/14737140.2019.1586539","volume":"19","author":"Gavriatopoulou","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1470-2045(19)30788-0","volume":"21","author":"Lonial","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.03.017","author":"Terpos","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s40265-019-01188-9","volume":"79","author":"Syed","year":"2019","journal-title":"Drugs"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1182\/blood-2017-08-797886","volume":"131","author":"Chen","year":"2018","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/leu.2012.219","volume":"27","author":"Etchin","year":"2013","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"8387","DOI":"10.2147\/OTT.S213208","volume":"12","author":"Depping","year":"2019","journal-title":"Onco Targets Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/leu.2013.115","volume":"28","author":"Tai","year":"2014","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/jcp.25378","volume":"231","author":"Taylor-Kashton","year":"2016","journal-title":"J Cell Physiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/leu.2013.172","volume":"27","author":"Schmidt","year":"2013","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.clml.2019.08.011","volume":"19","author":"Allegra","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","volume":"8","author":"Terpos","year":"2018","journal-title":"Blood Cancer J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.tranon.2017.04.010","volume":"10","author":"Muz","year":"2017","journal-title":"Transl Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/JCO.2017.75.5207","volume":"36","author":"Vogl","year":"2018","journal-title":"J clin oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"25529","DOI":"10.18632\/oncotarget.25368","volume":"9","author":"Argueta","year":"2018","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1016\/j.clml.2018.07.149","volume":"18","author":"Jagannath","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa1903455","volume":"381","author":"Chari","year":"2019","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.18632\/aging.101707","volume":"10","author":"Gavriatopoulou","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J clin oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1182\/blood-2016-11-752840","volume":"130","author":"Machlus","year":"2017","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"78896","DOI":"10.18632\/oncotarget.12969","volume":"7","author":"Turner","year":"2016","journal-title":"Oncotarget"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1182\/blood-2018-99-117201","volume":"132","author":"Gasparetto","year":"2018","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/14740338.2020.1713088","volume":"19","author":"Nishihori","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1182\/blood.V128.22.5662.5662","volume":"128","author":"Cui","year":"2016","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"9749","DOI":"10.1038\/s41598-017-10325-x","volume":"7","author":"Garg","year":"2017","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/1535-7163.MCT-15-0488","volume":"15","author":"Rosebeck","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.clml.2014.03.005","volume":"14","author":"Knopf","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref31","unstructured":"Available from: https:\/\/investors.karyopharm.com\/news-releases\/news-release-details\/karyopharm-announces-phase-3-boston-study-meets-primary-endpoint. Accessed June 22, 2020."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.1200\/JCO.2020.38.15_suppl.8501","volume":"38","author":"Dimopoulos","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/bjh.15969","volume":"186","author":"Jakubowiak","year":"2019","journal-title":"Br J Haematol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/14656566.2019.1707184","volume":"21","author":"Podar","year":"2020","journal-title":"Expert Opin Pharmacother"},{"volume-title":"SELINEXOR, POMALIDOMIDE, and DEXAMETHASONE (Spd) in PATIENTS with RELAPSED or REFRACTORY MULTIPLE MYELOMA","year":"2019","key":"ref35"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.1200\/JCO.2020.38.15_suppl.8530","volume":"38","author":"Gasparetto","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clml.2019.12.013","volume":"20","author":"Salcedo","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref38","unstructured":"White D, LeBlanc R, Venner C, et al. Safety and efficacy of the combination of selinexor, lenalidomide and dexamethasone (SRd) in patients with relapsed\/refractory multiple myeloma (RRMM). Abstract OAB-083 17th IMWG. September 12-15\/2019 Boston, MA, USA. 2019."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","volume":"373","author":"Lokhorst","year":"2015","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1182\/blood.V130.Suppl_1.3095.3095","volume":"130","author":"Baz","year":"2017","journal-title":"Blood"},{"key":"ref41","unstructured":"Tariq M, Farooqui A, Faisal M, et al. Efficacy and safety of selinexor for heavily pretreated multiple myeloma treatment \u2013 a systematic review. Abstract FP-115 17th IMWG. September 12-15\/2019. Boston, MA, USA; 2019."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1200\/EDBK_200889","volume":"38","author":"Cohen","year":"2018","journal-title":"Am Soc Clin Oncol Educa Book Am Soc Clin Oncol Ann Meeting"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1073\/pnas.1819745116","volume":"116","author":"Xu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.clml.2019.12.026","volume":"20","author":"Mikhael","year":"2020","journal-title":"Clinical Lymphoma Myeloma and Leukemia"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2016-11-750174","volume":"129","author":"Kuruvilla","year":"2017","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1200\/JCO.2015.65.3949","volume":"34","author":"Abdul Razak","year":"2016","journal-title":"J clin oncol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ygyno.2019.11.012","volume":"156","author":"Vergote","year":"2020","journal-title":"Gynecol Oncol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0756-6","author":"Gavriatopoulou","year":"2020","journal-title":"Leukemia"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16532","volume":"189","author":"Chakraborty","year":"2020","journal-title":"Br J Haematol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/10428194.2018.1509323","volume":"60","author":"Gavriatopoulou","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3324\/haematol.2016.148189","volume":"101","author":"Engelhardt","year":"2016","journal-title":"Haematologica"}],"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=59326","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=59326","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T20:41:45Z","timestamp":1593549705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/clinical-utility-of-selinexordexamethasone-in-patients-with-relapsed-o-peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":52,"URL":"https:\/\/doi.org\/10.2147\/ott.s227166","relation":{},"ISSN":["1178-6930"],"issn-type":[{"type":"electronic","value":"1178-6930"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}